EUCTR2012-000372-42-ES进行中（未招募）1 期
A Phase IV, open-label, prospective, randomised clinical trial to evaluate the usefulness of measuring nitric oxide in exhaled air in the therapeutic management of adult patients with mild asthma
Fundació per la Recerca i la Docència Sant Joan de Déu0 个研究点开始时间: 2012年4月17日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients who have previously given their informed consent to participate in the study will be included. a) Aged between 18 and 65 years. b) Initial diagnosis of mild persistent bronchial asthma according to the definition of the latest GEMA guidelines, well controlled with no exacerbations in the previous 3 months, ACT>20, normal spirometry and negative bronchodilator test. Patients already known and managed in the Pneumology Department of Parc Sanitari Sant Joan de Déu will be included. c) Atopy, defined as: elevated total IgE and/or allergy tests (skin prick or RAST testing) positive for respiratory pneumoallergens and/or peripheral eosinophilia.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 100
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 14
排除标准
- •a) Patients who do not fulfil the criteria defined in the GEMA guidelines for uncontrolled mild persistent bronchial asthma. b) Patients with an obstructive pattern on spirometry explained by another disease: COLD, sequelae of tuberculosis, bronchiolitis, etc. c) Patients who are clinically unstable at the time of inclusion or who have worsened in the 3 months prior to study inclusion. d) Patients who cannot correctly take treatment via the inhaled route. e) Patients with muscular disorders (myasthenia gravis, Parkinson’s). f) Patients who are smokers or ex-smokers. g) Patients requiring essential treatment which may produce bronchoconstriction of the airways (e.g. beta-blockers). h) Women who are pregnant or nursing. j) Patients included in any other research protocol.
研究者
相似试验
进行中（未招募）
1 期
A prospective, randomised, phase IV, open label clinical trial to study the therapeutic use of buprenorphine 20 mg (BuTrans 20µg/h) matrix transdermal patch in the management of post tonsillectomy pain in adults - PATCH TrialEUCTR2007-006117-16-GBBetsi Cadwaladr University Health Board300
进行中（未招募）
1 期
Immunogenicity and safety of the diphtheria, tetanus, pertussis and inactivated poliovirus (DPT-IPV) vaccine Squarekids™ co-administered with GSK Biologicals’ human rotavirus (HRV) vaccine Rotarix™ (444563) in healthy infants.Active immunisation of infants against gastroenteritis (GE) due to rotavirus (RV).MedDRA version: 19.0Level: SOCClassification code 10021881Term: Infections and infestationsSystem Organ Class: 10021881 - Infections and infestationsEUCTR2014-005282-78-Outside-EU/EEAGlaxoSmithKline Biologicals262
进行中（未招募）
1 期
A phase IV, randomized, open-label, controlled, post-licensure study to evaluate the safety of GlaxoSmithKline Biologicals’ HPV-16/18 L1 VLP AS04 vaccine (Cervarix®) when administered intramuscularly according to a 0, 1, 6-month schedule in females aged 18-25 years. - EPI-HPV-111103o medical condition will be investigated in this study. The study will follow vaccinated females and collect safety data focussing on autoimmune diseases, pregnancy outcomes and SAEs considered to be related to the vaccine.EUCTR2007-006651-39-GBGlaxoSmithKline Biologicals100,000
进行中（未招募）
1 期
DREAM studyEUCTR2016-004646-29-ESFundación SEIMC-GESIDA64
进行中（未招募）
1 期
This study compares clinically and microscopically the response to two treatments, a steroid in cream and a foam that contains a steroid and a vitamin D analogue in patients with plaque psoriasis.Plaque psoriasisEUCTR2017-004451-24-ESFundació Clínic per a la Reserca Biomèdica36